{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:55Z","timestamp":1792782955797,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Excellent youth project of the Fourth Affiliated Hospital of Harbin Medical University","award":["HYDSYYXQN2023004"],"award-info":[{"award-number":["HYDSYYXQN2023004"]}],"id":[{"id":"https:\/\/ror.org\/02s7c9e98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PC) is one of the malignant tumors with high incidence and mortality worldwide in men. Immune cells in the tumor microenvironment (TME), particularly mast cells, play important roles in tumor progression and prognosis. However, the dual roles of mast cells in PC have not been fully elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, single-cell RNA sequencing (scRNA-seq), bulk RNA sequencing, and bioinformatics analyses were performed to investigate the heterogeneity of mast cell subsets in the TME of PC and their association with prognosis. Single-cell data from 39 PC tumor samples were analyzed, and prognostic prediction was validated using datasets including HMU, TCGA, and MSKCC cohorts. Non-negative matrix factorization was applied to cluster mast cell subsets, followed by analyses of subset-specific gene markers, transcription factor activity, and biological pathways. Survival analysis and ROC curve evaluation were conducted to assess prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mast cells in the TME of PC were classified into two distinct subsets, each characterized by unique gene markers and functional pathways. Mast cell1 was highly associated with pro-tumorigenic pathways, whereas mast cell2 predominantly exhibited antitumor immune regulatory properties. High expression of mast cell1 signatures was correlated with poorer survival outcomes, while high expression of mast cell2 signatures was associated with better survival. Key marker genes such as BIRC3 and FOS were identified as potential prognostic factors, high BIRC3 expression was significantly associated with unfavorable prognosis, whereas high FOS expression correlated with favorable prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study revealed functional heterogeneity of mast cell subsets in the TME of PC and their distinct roles in tumor progression. The identification of subset-specific marker genes provides novel molecular targets for clinical diagnosis, prognostic prediction, and personalized therapy in PC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00262-026-04363-6","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:25:39Z","timestamp":1774355139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heterogeneity and prognostic significance of mast cell subsets in the tumor microenvironment of prostate cancer"],"prefix":"10.1007","volume":"75","author":[{"given":"Ruizhe","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggui","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruicong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"4363_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"4363_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND et al (2024) The lancet commission on prostate cancer: planning for the surge in cases. Lancet 403:1683\u20131722. https:\/\/doi.org\/10.1016\/S0140-6736(24)00651-2","journal-title":"Lancet"},{"key":"4363_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","volume":"209","author":"W Lowrance","year":"2023","unstructured":"Lowrance W et al (2023) Updates to advanced prostate cancer: AUA\/SUO guideline (2023). J Urol 209:1082\u20131090. https:\/\/doi.org\/10.1097\/JU.0000000000003452","journal-title":"J Urol"},{"key":"4363_CR4","doi-asserted-by":"publisher","first-page":"106058","DOI":"10.1016\/j.ebiom.2025.106058","volume":"123","author":"N Portman","year":"2025","unstructured":"Portman N et al (2025) Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells. EBioMedicine 123:106058. https:\/\/doi.org\/10.1016\/j.ebiom.2025.106058","journal-title":"EBioMedicine"},{"key":"4363_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O et al (2023) 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol 84:191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021","journal-title":"Eur Urol"},{"key":"4363_CR6","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1200\/JCO.2010.27.9992","volume":"28","author":"C Ferrone","year":"2010","unstructured":"Ferrone C, Dranoff G (2010) Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 28:4045\u20134051. https:\/\/doi.org\/10.1200\/JCO.2010.27.9992","journal-title":"J Clin Oncol"},{"key":"4363_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-022-01050-w","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang Z et al (2022) Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response. Genome Med 14:45. https:\/\/doi.org\/10.1186\/s13073-022-01050-w","journal-title":"Genome Med"},{"key":"4363_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000513582","volume":"13","author":"A Paivandy","year":"2021","unstructured":"Paivandy A, Pejler G (2021) Novel strategies to target mast cells in disease. J Innate Immun 13:131\u2013147. https:\/\/doi.org\/10.1159\/000513582","journal-title":"J Innate Immun"},{"key":"4363_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ni.f.216","volume":"9","author":"J Kalesnikoff","year":"2008","unstructured":"Kalesnikoff J, Galli SJ (2008) New developments in mast cell biology. Nat Immunol 9:1215\u20131223. https:\/\/doi.org\/10.1038\/ni.f.216","journal-title":"Nat Immunol"},{"key":"4363_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccell.2017.03.006","volume":"31","author":"AR Poh","year":"2017","unstructured":"Poh AR et al (2017) Inhibition of hematopoietic cell kinase activity suppresses myeloid cell-mediated colon cancer progression. Cancer Cell 31:563\u2013575. https:\/\/doi.org\/10.1016\/j.ccell.2017.03.006","journal-title":"Cancer Cell"},{"key":"4363_CR11","doi-asserted-by":"publisher","first-page":"116863","DOI":"10.1016\/j.celrep.2025.116863","volume":"45","author":"J Zhao","year":"2026","unstructured":"Zhao J et al (2026) Activated CD38(+) mast cells promote gastric cancer progression by suppressing CD8(+) T cell cytotoxic activity through adenosine metabolism. Cell Rep 45:116863. https:\/\/doi.org\/10.1016\/j.celrep.2025.116863","journal-title":"Cell Rep"},{"key":"4363_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J (2020) The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 20:662\u2013680. https:\/\/doi.org\/10.1038\/s41568-020-0285-7","journal-title":"Nat Rev Cancer"},{"key":"4363_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1158\/2326-6066.CIR-13-0119","volume":"1","author":"T Marichal","year":"2013","unstructured":"Marichal T, Tsai M, Galli SJ (2013) Mast cells: potential positive and negative roles in tumor biology. Cancer Immunol Res 1:269\u2013279. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0119","journal-title":"Cancer Immunol Res"},{"key":"4363_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/ejh.12747","volume":"97","author":"A Englund","year":"2016","unstructured":"Englund A et al (2016) The role of tumour-infiltrating eosinophils, mast cells and macrophages in classical and nodular lymphocyte predominant Hodgkin lymphoma in children. Eur J Haematol 97:430\u2013438. https:\/\/doi.org\/10.1111\/ejh.12747","journal-title":"Eur J Haematol"},{"key":"4363_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/ejh.12583","volume":"96","author":"MD Andersen","year":"2016","unstructured":"Andersen MD et al (2016) Tumour-associated mast cells in classical Hodgkin\u2019s lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome. Eur J Haematol 96:252\u2013259. https:\/\/doi.org\/10.1111\/ejh.12583","journal-title":"Eur J Haematol"},{"key":"4363_CR16","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.4049\/jimmunol.1301350","volume":"191","author":"M Antsiferova","year":"2013","unstructured":"Antsiferova M et al (2013) Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis. J Immunol 191:6147\u20136155. https:\/\/doi.org\/10.4049\/jimmunol.1301350","journal-title":"J Immunol"},{"key":"4363_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Gerstein M, Snyder M (2009) RNA-seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57\u201363. https:\/\/doi.org\/10.1038\/nrg2484","journal-title":"Nat Rev Genet"},{"key":"4363_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/bib\/bbs046","volume":"14","author":"MA Dillies","year":"2013","unstructured":"Dillies MA et al (2013) A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform 14:671\u2013683. https:\/\/doi.org\/10.1093\/bib\/bbs046","journal-title":"Brief Bioinform"},{"key":"4363_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"4363_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T et al (2023) Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun 14:663. https:\/\/doi.org\/10.1038\/s41467-023-36325-2","journal-title":"Nat Commun"},{"key":"4363_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","volume":"563","author":"R Vento-Tormo","year":"2018","unstructured":"Vento-Tormo R et al (2018) Single-cell reconstruction of the early maternal-fetal interface in humans. Nature 563:347\u2013353. https:\/\/doi.org\/10.1038\/s41586-018-0698-6","journal-title":"Nature"},{"key":"4363_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S et al (2017) SCENIC: single-cell regulatory network inference and clustering. Nat Methods 14:1083\u20131086. https:\/\/doi.org\/10.1038\/nmeth.4463","journal-title":"Nat Methods"},{"key":"4363_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS et al (2020) Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367:405\u2013411. https:\/\/doi.org\/10.1126\/science.aax0249","journal-title":"Science"},{"key":"4363_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X et al (2017) Single-cell mRNA quantification and differential analysis with Census. Nat Methods 14:309\u2013315. https:\/\/doi.org\/10.1038\/nmeth.4150","journal-title":"Nat Methods"},{"key":"4363_CR25","doi-asserted-by":"publisher","first-page":"e71362","DOI":"10.1096\/fj.202503144R","volume":"39","author":"Z Tan","year":"2025","unstructured":"Tan Z et al (2025) Single-cell multi-omics reveals B2M-mediated myeloid reprogramming and constructs a predictive model for early hepatocellular carcinoma recurrence. FASEB J 39:e71362. https:\/\/doi.org\/10.1096\/fj.202503144R","journal-title":"FASEB J"},{"key":"4363_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13578-025-01496-6","volume":"15","author":"Z Wang","year":"2025","unstructured":"Wang Z et al (2025) KDM6B inhibition enhances chemotherapeutic response in small cell lung cancer via epigenetic regulation of apoptosis and ferroptosis. Cell Biosci 15:162. https:\/\/doi.org\/10.1186\/s13578-025-01496-6","journal-title":"Cell Biosci"},{"key":"4363_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41419-022-05180-2","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J et al (2022) MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma. Cell Death Dis 13:727. https:\/\/doi.org\/10.1038\/s41419-022-05180-2","journal-title":"Cell Death Dis"},{"key":"4363_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13578-023-01144-x","volume":"13","author":"Z Xie","year":"2023","unstructured":"Xie Z et al (2023) Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment. Cell Biosci 13:217. https:\/\/doi.org\/10.1186\/s13578-023-01144-x","journal-title":"Cell Biosci"},{"key":"4363_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41388-022-02543-z","volume":"42","author":"F Song","year":"2023","unstructured":"Song F et al (2023) Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C. Oncogene 42:209\u2013223. https:\/\/doi.org\/10.1038\/s41388-022-02543-z","journal-title":"Oncogene"},{"key":"4363_CR30","doi-asserted-by":"publisher","first-page":"1209056","DOI":"10.3389\/fimmu.2023.1209056","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Li X, Wei H, Liu Y, Li N (2023) Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis. Front Immunol 14:1209056. https:\/\/doi.org\/10.3389\/fimmu.2023.1209056","journal-title":"Front Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04363-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:25:39Z","timestamp":1774355139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04363-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4363"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04363-6","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of Harbin Medical University and conducted in accordance with the Declaration of Helsinki (YJSKY2024-188).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"118"}}